Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New AI Algorithm Makes Liver Cancer Surgery Safer

By HospiMedica International staff writers
Posted on 07 Jun 2018
Researchers at the Fraunhofer Institute for Medical Image Computing MEVIS (Bremen, Germany) have developed algorithms that analyze patients’ imaging data and calculate surgical risks, making liver cancer surgery safer and easier to plan. More...
Researchers at Fraunhofer have been working on image-processing algorithms for use in medicine since 1998. The method is now widely known among physicians as MEVIS analysis and has become established in practice.

Surgery continues to offer the best chance of recovery among patients with liver cancer or those with liver metastases caused by other cancers. However, the complex, entangled human vascular anatomy makes it difficult to reconstruct mentally based on CT or MRI images alone. The new software analyzes a patient’s radiological images, and generates a detailed three-dimensional model of the liver and its vascular systems. It calculates the supply and drainage areas of the blood vessels and helps to determine the risks of possible tumors resection strategies. The information can be used by surgeons to prepare their surgery accurately by planning the optimal resection virtually. The analysis of vascular anatomy in the vicinity of the tumor also helps locate critical sections of the planned procedure. The surgeon receives a risk map of the resection path and knows where there is little room for deviations from the optimal cutting plane, such as where the planned resection corridor is particularly narrow.

The researchers have also developed an iPad app that combines the planning data with augmented reality. When the doctor turns on the iPad camera and directs it at the patient’s liver, the three-dimensional image of the patient’s liver, previously generated using the algorithms, is superimposed onto the image of the camera and shows the position of the blood vessels and tumors beneath the liver surface.

According to studies, liver surgery is more efficient and safer with the MEVIS analysis. Additionally blood loss can also be reduced. In some cases, the analysis algorithms allow surgeons to safely perform even delicate operations, which would have been considered too risky without the software. The software also generates suggestions for performing resections. "However, these are only proposals. Ultimately, the decision has to be made by the surgeon," said Dr. Andrea Schenk, Head of Liver Research at the Fraunhofer MEVIS.

Related Links:
Fraunhofer Institute for Medical Image Computing MEVIS


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.